Montanide ISA-51
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Montanide ISA-51, covering 2012-06-22 to 2021-07-15. Get the full timeline:
Most recent: Clinical Trial Update: A Pilot Study of NY-ESO-1b Peptide Plus CpG 7909 and Montanide® ISA-51 in Patients With Cancer. [Phase 1]